Related Experiment Videos

[Hypertension in pregnancy]

Fabio Lunati1, Maurizio Dugnani, Mauro Campanini

  • 1II Divisione Medicina Interna, Azienda Ospedaliera Maggiore della Carità, Novara.

Recenti Progressi in Medicina
|December 3, 2008
PubMed

Insights

Hypertension in pregnancy lacks a clear definition, with severe forms like pre-eclampsia requiring early diagnosis. Current evidence does not support pharmacological treatment for improved maternal or fetal outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Pharmacology

Context:

  • Hypertension in pregnancy presents diagnostic challenges and lacks a universally agreed-upon definition.
  • Severe complications, including pre-eclampsia and eclampsia, necessitate timely diagnosis and management.
  • The therapeutic landscape for pregnancy-induced hypertension remains under investigation, with limited evidence supporting pharmacological interventions.

Purpose:

  • To review the current literature on the definition, diagnosis, and therapeutic options for hypertension in pregnancy.
  • To highlight the challenges in managing pre-eclampsia and eclampsia.
  • To identify gaps in knowledge regarding pharmacological treatments and their impact on maternal and fetal outcomes.

Summary:

  • There is no consensus on defining hypertension during pregnancy.
  • Early diagnosis of severe conditions like pre-eclampsia and eclampsia is crucial.
  • Evidence supporting the positive impact of pharmacological treatments on maternal/fetal outcomes is lacking.
  • Alpha-methyldopa is recommended for blood pressure < 180/110 mmHg.
  • Nifedipine, methyldopa, beta-blockers, and hydralazine show efficacy in specific contexts, particularly pre-eclampsia.

Impact:

  • Highlights the need for standardized definitions and diagnostic criteria for hypertensive disorders in pregnancy.
  • Underscores the importance of early detection and management of pre-eclampsia and eclampsia.
  • Identifies critical research gaps in the pharmacological treatment of pregnancy hypertension, guiding future clinical studies and evidence-based guidelines.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.